Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

518 public trials 102 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Recruiting

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

NCT06312137

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +11 more
Locations
  • UAMS Winthrop P. Rockefeller Cancer Institute ( Site 0060) Little Rock, Arkansas, United States
  • Highlands Oncology Group-Research Department ( Site 0062) Springdale, Arkansas, United States
  • Beverly Hills Cancer Center ( Site 0070) Beverly Hills, California, United States
  • The Angeles Clinic and Research Institute ( Site 0040) Los Angeles, California, United States
View all 267 locations
View Trial Details
Recruiting

Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer

NCT07195734

Conditions
Carcinoma, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, +33 more
Locations
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sutter Medical Center Sacramento Sacramento, California, United States
View all 100 locations
View Trial Details
Recruiting

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT02734537

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +34 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 676 locations
View Trial Details
Recruiting

Ph1b/2 Study of the Safety and Efficacy of T-DXd Combinations in Advanced HER2-expressing Gastric Cancer (DESTINY-Gastric03)

NCT04379596

Conditions
Adenocarcinoma, Carcinoma, Digestive System Diseases, +13 more
Locations
  • Research Site Santa Monica, California, United States
  • Research Site Westwood, Kansas, United States
  • Research Site Baltimore, Maryland, United States
  • Research Site Boston, Massachusetts, United States
View all 100 locations
View Trial Details
Recruiting

A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers

NCT05873686

Conditions
Adenocarcinoma, Adenoma, Advanced Solid Tumor, +28 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 15 locations
View Trial Details
Recruiting

Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer

NCT07257094

Conditions
Carcinoma, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, +5 more
Locations
  • CHU Caen Caen, France
  • Centre Antoine Lacassagne Nice, France
  • Institut Curie Paris, France
  • Hôpital Lariboisière (AP-HP) Paris, France
View Trial Details
Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more
Locations
  • Mayo Clinic Building- Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 128 locations
View Trial Details
Recruiting

A Study of Zipalertinib in Patients With Advanced Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertions or Other Uncommon Mutation.

NCT05967689

Conditions
Advanced or Metastatic NSCLC Harboring Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion (ex20ins) Mutations, Carcinoma, Lung Diseases, +4 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope - Duarte Duarte, California, United States
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
  • Comprehensive Cancer Centers of Nevada - Central Valley - Twain Las Vegas, Nevada, United States
View all 80 locations
View Trial Details
Recruiting

Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer

NCT04614103

Conditions
Bronchial Diseases, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Banner Health MD Anderson Gilbert, Arizona, United States
  • Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
  • Rush University Medical Center Chicago, Illinois, United States
View all 71 locations
View Trial Details

Related conditions